[ Price : $8.95]
FDA releases the October-December 2021 safety signal report with 40 listings from the FDA Adverse Events Reporting System.[ Price : $8.95]
Medtronic says a clinical trial showed that patients who were prescribed anti-hypertensive medications and treated with its Sympli...[ Price : $8.95]
FDA approves a BioXcel Therapeutics NDA for Igalmi (dexmedetomidine) sublingual film for the acute treatment of agitation associat...[ Price : $8.95]
FDA officials say that a decision will likely be made in June on whether a new Covid-19 booster composition is needed by November ...[ Price : $8.95]
Six drug companies comment on an FDA draft guidance on assessing drug presser effects.[ Price : $8.95]
Federal Register notice: FDA announces that six information collections that have been approved by OMB.[ Price : $8.95]
A new FDA whitepaper outlines the agencys plans to advance a framework to objectively rate pharmaceutical manufacturing sites Qual...[ Price : $8.95]
FDA grants priority review for Sanofi and Regenerons sBLA for a new Dupixent indication.